Cargando…
The Immunology of Macrophage Activation Syndrome
Synonymous with secondary hemophagocytic lymphohistiocytosis, macrophage activation syndrome (MAS) is a term used by rheumatologists to describe a potentially life-threatening complication of systemic inflammatory disorders, most commonly systemic juvenile idiopathic arthritis (sJIA) and systemic lu...
Autores principales: | Crayne, Courtney B., Albeituni, Sabrin, Nichols, Kim E., Cron, Randy Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367262/ https://www.ncbi.nlm.nih.gov/pubmed/30774631 http://dx.doi.org/10.3389/fimmu.2019.00119 |
Ejemplares similares
-
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
por: Keenan, Camille, et al.
Publicado: (2021) -
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
por: Eloseily, Esraa M. A., et al.
Publicado: (2019) -
Patterns of B Cell Repletion Following Rituximab Therapy in a Pediatric Rheumatology Cohort
por: Mitchell, Chace, et al.
Publicado: (2019) -
Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis
por: Albeituni, Sabrin, et al.
Publicado: (2023) -
Macrophage Activation Syndrome
por: Eloseily, Esraa M., et al.
Publicado: (2018)